P53 alteration correlates with negative ER, negative PGR, and high histologic grade in breast cancer
β Scribed by Mitsunori Sasa; Kazuya Kondo; Kansei Komaki; Tadaoki Morimoto; Yasumasa Monden
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 394 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Seventy tumors of invasive ductal carcinoma of the breast were examined for p53 alteration by the RT-PCR-SSCP method. Sixty-five samples (92.9%) were investigated in the regions of codons 101-200 and 201-300. In total, 16 samples (24.6%) showed p53 gene alteration. We found that p53 gene alteration showed a correlation with (1) a negative ER status, (2) a negative PgR status, and (3) a high histologic grade (especially numerous mitotic figures) of the tumor. However, we found no correlation between p53 gene alteration and the lymph node status or clinical stage. Thus, p53 gene alteration in breast cancer may occur in highly malignant breast cancer other than advanced clinical stage cancer or node-positive cancer.
π SIMILAR VOLUMES
Sixty-six unselected breast cancers were analyzed in cytologic smears and histologic sections for the expression of proliferating cell nuclear antigen (PCNA), estrogen receptor protein (ERP), and p53 protein using a standard immunochemical method. The results, expressed as both positive cases and la
## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclinβdependent kinase inhibitor p27(Kip1) in patients with earlyβstage breast carcinoma and to investigate its relation with clinicopathologic features and other m